Om Prakash Selected Research

Indenes

2/2016

Indenes and tetralenes analogues attenuates lipopolysaccharide-induced inflammation: An in-vitro and in-vivo study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Om Prakash Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 06/2002
13	Infections 09/2021 - 07/2002
8	COVID-19 03/2022 - 01/2021
6	Inflammation (Inflammations) 12/2016 - 06/2010
5	Carcinogenesis 01/2022 - 10/2006
4	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2013
4	Body Weight (Weight, Body) 05/2018 - 07/2008
4	Parkinson Disease (Parkinson's Disease) 12/2016 - 04/2012
3	Hyperglycemia 03/2022 - 01/2011
3	Diabetes Mellitus 03/2022 - 01/2011
3	Dengue (Dengue Fever) 09/2021 - 01/2015
3	B-Cell Lymphoma (Lymphoma, B Cell) 12/2016 - 05/2005
3	Parkinsonian Disorders (Parkinsonism) 12/2016 - 04/2012
3	Dementia (Dementias) 07/2012 - 10/2009
3	Alzheimer Disease (Alzheimer's Disease) 01/2010 - 09/2009
3	Lymphoma (Lymphomas) 03/2007 - 06/2002
2	Malaria 10/2022 - 04/2014
2	Tuberculosis (Tuberculoses) 09/2020 - 09/2009
2	Prostatic Neoplasms (Prostate Cancer) 01/2017 - 01/2008
2	Necrosis 12/2016 - 07/2008
2	Liver Neoplasms (Liver Cancer) 01/2016 - 01/2013
2	Sepsis (Septicemia) 09/2014 - 02/2006
2	Coinfection 02/2014 - 07/2012
2	Fever (Fevers) 02/2014 - 12/2012
2	Acquired Immunodeficiency Syndrome (AIDS) 07/2012 - 05/2012
2	Mania (Manias) 05/2012 - 08/2009
2	Type 2 Diabetes Mellitus (MODY) 11/2011 - 01/2011
2	Channelopathies 08/2010 - 03/2004
2	Cystic Fibrosis (Mucoviscidosis) 08/2010 - 03/2004
2	Kaposi Sarcoma (Kaposi's Sarcoma) 03/2007 - 08/2002
2	Sarcoma (Soft Tissue Sarcoma) 01/2007 - 07/2005
1	Mucormycosis 03/2022
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 03/2022
1	Pancreatitis 01/2022
1	Severe Acute Respiratory Syndrome 01/2022
1	Virus Diseases (Viral Diseases) 09/2021
1	Choledocholithiasis 01/2021
1	Hernia (Hernias) 01/2021
1	Cholelithiasis 01/2021
1	Inguinal Hernia (Direct Inguinal Hernia) 01/2021

Drug/Important Bio-Agent (IBA)

7	CytokinesIBA 01/2022 - 06/2002
6	AntibodiesIBA 01/2022 - 02/2014
6	Immunoglobulin G (IgG)IBA 01/2022 - 01/2021
6	Pharmaceutical PreparationsIBA 01/2019 - 10/2009
6	Proteins (Proteins, Gene)FDA Link 05/2018 - 05/2005
5	NF-kappa B (NF-kB)IBA 01/2022 - 06/2002
5	Biological ProductsIBA 01/2022 - 11/2011
4	Peptides (Polypeptides)IBA 10/2022 - 03/2004
4	VaccinesIBA 01/2022 - 08/2015
4	Antipsychotic Agents (Antipsychotics)IBA 06/2014 - 08/2009
4	Hypoglycemic Agents (Hypoglycemics)IBA 11/2013 - 05/2011
3	Phosphotransferases (Kinase)IBA 01/2022 - 06/2002
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 08/2002
3	RNA (Ribonucleic Acid)IBA 07/2021 - 01/2015
3	PhytochemicalsIBA 01/2020 - 01/2019
3	FlavonoidsIBA 01/2020 - 12/2012
3	AntioxidantsIBA 01/2020 - 12/2014
3	Dopamine (Intropin)FDA LinkGeneric 12/2016 - 04/2012
2	Hormones (Hormone)IBA 10/2022 - 01/2008
2	Insulin (Novolin)FDA Link 03/2022 - 05/2011
2	SteroidsIBA 03/2022 - 12/2012
2	Blood Glucose (Blood Sugar)IBA 03/2022 - 05/2011
2	Oxidoreductases (Dehydrogenase)IBA 01/2022 - 01/2006
2	Immunoglobulin M (IgM)IBA 07/2021 - 02/2014
2	Estrogen ReceptorsIBA 02/2020 - 01/2020
2	Progesterone Receptors (Progesterone Receptor)IBA 02/2020 - 01/2020
2	cypermethrin (alphamethrin)IBA 12/2016 - 12/2014
2	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2016 - 07/2012
2	LipopolysaccharidesIBA 02/2016 - 01/2014
2	Antineoplastic Agents (Antineoplastics)IBA 01/2016 - 01/2014
2	ManebIBA 08/2013 - 04/2012
2	ParaquatIBA 08/2013 - 04/2012
2	EnzymesIBA 01/2011 - 01/2006
2	Antimicrobial PeptidesIBA 07/2008 - 05/2005
1	Amino Acids FDA Link 10/2022
1	Peptide Hormones (Polypeptide Hormones)IBA 10/2022
1	NeuropeptidesIBA 10/2022
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2022
1	naringeninIBA 01/2022
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2022
1	TubulinIBA 01/2022
1	Cathepsin KIBA 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 01/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	Aromatase (CYP19)IBA 01/2022
1	ImmunosorbentsIBA 09/2021
1	4- (2- (4- isopropylbenzamido)ethoxy)benzoic acidIBA 07/2021
1	AntigensIBA 07/2021
1	WastewaterIBA 05/2021
1	Viral RNAIBA 05/2021
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2021
1	tetra-4-amidinophenoxypropane (TAPP)IBA 01/2021
1	tetraethylpyrazine (TEP)IBA 01/2021

Therapy/Procedure

14	Therapeutics 03/2022 - 07/2002
3	Oral Administration 02/2016 - 05/2011
2	Chemoprevention 01/2022 - 01/2019
1	Cholecystectomy 01/2022
1	Laparoscopic Cholecystectomy 01/2021
1	Herniorrhaphy 01/2021